Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in Infants
ChiCTR2100042394Phase 3Recruiting
- Sponsor
- Guangxi Center for Disease Control and Prevention
- Start
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal meningitis (3 arms), sponsored by Guangxi Center for Disease Control and Prevention. Primary endpoint: Serum bactericidal antibodies against meningococcal groups A, C, Y and W135 (rSBA). Started Aug 2020; status: recruiting.
02
Drugs
A, C, Y, W135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on ChiCTR2100042394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042394.